All enrolled individuals who obtained at the least one particular dose of zosuquidar or placebo through induction ended up monitored for that event of adverse occasions (439 patients, 219 on zosuquidar and 210 on placebo). The commonest adverse functions had been associated with the duration of extended and major myelosuppression https://christopherv343sfs7.therainblog.com/profile